未登录

A

Andrei V. Bakin

Roswell Park Comprehensive Cancer Center

H指数:39

被引数:7,394

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab

TP53突变与接受西妥昔单抗和帕博利珠单抗治疗的晚期RAS野生型结直肠腺癌患者疾病控制改善相关。

International Journal of Cancer

IF4.7

2026-03-070

PRE

A synergistic two-drug therapy selectively targeting DNA repair dysregulation in p53-deficient cancers

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-010

PRE

TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial

BRITISH JOURNAL OF CANCER

IF6.8

2024-09-070

PRE

Novel therapeutic approach for targeting p53 mutant colorectal cancers by affecting post-replicative DNA repair

CANCER RESEARCH

IF16.6

2024-03-220

PRE

The role of p38 MAPK in the tumor-induced immune suppressive microenvironment in metastatic breast cancer

CANCER RESEARCH

IF16.6

2024-03-220

PRE

A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers

CELL REPORTS MEDICINE

IF10.6

2024-03-014

OAAI

Evaluation of a novel two-drug combination strategy for p53-deficient colorectal and pancreatic cancers

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Dissection of a Down syndrome-associated trisomy to separate the gene dosage-dependent and -independent effects of an extra chromosome

HUMAN MOLECULAR GENETICS

IF3.2

2023-04-047

OA

Blockade of p38 MAPK reduces the tumor-induced immune suppressive microenvironment in metastatic breast cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

A synthetic lethality treatment strategy for p53 mutant breast cancer

CANCER RESEARCH

IF16.6

2022-02-150

PRE

P38 kinase as a therapeutic target to reverse an immune suppressive tumor microenvironment in metastatic breast cancer

CANCER RESEARCH

IF16.6

2022-02-150

PRE

Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair

COMMUNICATIONS BIOLOGY

IF5.1

2021-07-128

OAAI

TAK1 signaling regulates p53 through a mechanism involving ribosomal stress

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Blockade of p38 kinase impedes the mobilization of protumorigenic myeloid populations to impact breast cancer metastasis

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2020-05-2810

OA

TAK1 signaling regulates p53 through a mechanism involving ribosomal stress

SCIENTIFIC REPORTS

IF3.9

2020-02-138

OAAI

Suppression of tumor angiogenesis and metastasis by targeting a novel p38-driven tumor-stromal crosstalk

CANCER RESEARCH

IF16.6

2019-07-010

PRE

XBP1-KLF9 Axis Acts as a Molecular Rheostat to Control the Transition from Adaptive to Cytotoxic Unfolded Protein Response

IF6.9

2018-10-0138

OAAI

TGF-β signaling promotes tumor vasculature by enhancing the pericyte-endothelium association

IF3.4

2018-06-1971

OAAI

Internally ratiometric fluorescent sensors for evaluation of intracellular GTP levels and distribution

IF32.1

2017-09-0447

OA

Cross-talk of the cytokine pathways in cancer progression

CANCER RESEARCH

IF16.6

2015-08-010

PRE